Adrian Valeriu Neacșu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adrian Valeriu Neacșu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adina Elena Nenciu
Department of Obstetrics and Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
3 shared publications - Alina-Alexandra Dîrlău
Obstetrics and Gynecology Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
2 shared publications - Iuliana Ceausu
Department of Obstetrics and Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
2 shared publications - Oana Eliza Cretu
Obstetrics and Gynecology Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
2 shared publications - Șerban Nastasia
Department of Obstetrics and Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
2 shared publications Adina-Elena Nenciu
1 shared publication
Latest Publications
- Open Access
- 26 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7593
The Role of microRNA-210 in the Pathogenesis and Diagnosis of Preeclampsia—A Systematic Review
Background: Preeclampsia is a complex hypertensive disorder of pregnancy associated with significant maternal and foetal morbidity and mortality. Its pathogenesis involves placental hypoxia, oxidative stress, and impaired trophoblast invasion. Recent evidence highlights the role of microRNAs, particularly microRNA-210 (miR-210), in the molecular disruptions underlying preeclampsia. Aim: This study aims to explore the pathogenic, diagnostic, and therapeutic significance of miR-210 in preeclampsia, with emphasis on its molecular mechanisms, biomarker potential, and prospects as a therapeutic target. Methods: A systematic narrative review was conducted following PRISMA guidelines. A total of 498,184 articles were identified through eight scientific databases, and, after duplicate removal and eligibility screening, 111 peer-reviewed studies published between 2015 and 2025 were included in the final analysis. The selected literature focused on miR-210’s expression in placental tissue and maternal circulation, its molecular targets, and its clinical relevance. Results: miR-210 is consistently upregulated in preeclamptic placentas and maternal plasma. It contributes to shallow trophoblast invasion, impaired angiogenesis, mitochondrial dysfunction, and the activation of a hypoxia-induced HIF-1α feedback loop. These mechanisms are central to the disease’s pathophysiology. Clinically, miR-210 demonstrates high stability in circulation and early detectability, making it a promising diagnostic and prognostic biomarker. Experimental models have also demonstrated the therapeutic potential of miR-210 inhibition using antisense oligonucleotides or HIF-1α modulators. Conclusions: miR-210 is both a marker and mediator of preeclampsia. Its integration into diagnostic protocols and therapeutic strategies, alongside clinical validation and standardisation, may enhance early detection and personalised care in high-risk pregnancies.
- 26 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7593
Open AccessThe Role of microRNA-210 in the Pathogenesis and Diagnosis of Preeclampsia—A Systematic Review
Background: Preeclampsia is a complex hypertensive disorder of pregnancy associated with significant maternal and foetal morbidity and mortality. Its pathogenesis involves placental hypoxia, oxidative stress, and impaired trophoblast invasion. Recent evidence highlights the role of microRNAs, particularly microRNA-210 (miR-210), in the molecular disruptions underlying preeclampsia. Aim: This study aims to explore the pathogenic, diagnostic, and therapeutic significance of miR-210 in preeclampsia, with emphasis on its molecular mechanisms, biomarker potential, and prospects as a therapeutic target. Methods: A systematic narrative review was conducted following PRISMA guidelines. A total of 498,184 articles were identified through eight scientific databases, and, after duplicate removal and eligibility screening, 111 peer-reviewed studies published between 2015 and 2025 were included in the final analysis. The selected literature focused on miR-210’s expression in placental tissue and maternal circulation, its molecular targets, and its clinical relevance. Results: miR-210 is consistently upregulated in preeclamptic placentas and maternal plasma. It contributes to shallow trophoblast invasion, impaired angiogenesis, mitochondrial dysfunction, and the activation of a hypoxia-induced HIF-1α feedback loop. These mechanisms are central to the disease’s pathophysiology. Clinically, miR-210 demonstrates high stability in circulation and early detectability, making it a promising diagnostic and prognostic biomarker. Experimental models have also demonstrated the therapeutic potential of miR-210 inhibition using antisense oligonucleotides or HIF-1α modulators. Conclusions: miR-210 is both a marker and mediator of preeclampsia. Its integration into diagnostic protocols and therapeutic strategies, alongside clinical validation and standardisation, may enhance early detection and personalised care in high-risk pregnancies.
- Open Access
- 20 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5149
Obstetrical Follow-Up in Pregnancies After Radical Trachelectomy—Our Case Series and Proposed Cervical Length Measurement Protocol
Background/Objectives: Obstetrical monitoring following radical trachelectomy (RT) for cervical cancer is marked by the lack of a standardized protocol, which may lead to delays in the intervention for cervical shortening. In light of the typical cervical remodeling process that occurs at the onset of labor, we hypothesized that the onset of premature cervical shortening in patients who have undergone radiotherapy commences at the internal ostium. Methods: We introduced the concepts of internal distance (distance between internal cervical ostium and cerclage thread) and the latent shortening of internal distance, which is characterized as a painless reduction in the internal distance, serving as an early marker of preterm contractions, thus enabling timely tocolytic intervention. Results: Three patients spontaneously conceived after RT. They were obstetrically followed-up after RT, using a combined approach of transvaginal ultrasound cervical markers and cardiotocography. Active tocolysis was used if internal distance shortening was observed. All patients delivered term healthy babies. Conclusions: The consistent ultrasound evaluation of both internal and external distances permits the proactive diagnosis of premature contractions and enables swift therapeutic measures.
- 20 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5149
Open AccessObstetrical Follow-Up in Pregnancies After Radical Trachelectomy—Our Case Series and Proposed Cervical Length Measurement Protocol
Background/Objectives: Obstetrical monitoring following radical trachelectomy (RT) for cervical cancer is marked by the lack of a standardized protocol, which may lead to delays in the intervention for cervical shortening. In light of the typical cervical remodeling process that occurs at the onset of labor, we hypothesized that the onset of premature cervical shortening in patients who have undergone radiotherapy commences at the internal ostium. Methods: We introduced the concepts of internal distance (distance between internal cervical ostium and cerclage thread) and the latent shortening of internal distance, which is characterized as a painless reduction in the internal distance, serving as an early marker of preterm contractions, thus enabling timely tocolytic intervention. Results: Three patients spontaneously conceived after RT. They were obstetrically followed-up after RT, using a combined approach of transvaginal ultrasound cervical markers and cardiotocography. Active tocolysis was used if internal distance shortening was observed. All patients delivered term healthy babies. Conclusions: The consistent ultrasound evaluation of both internal and external distances permits the proactive diagnosis of premature contractions and enables swift therapeutic measures.
- Open Access
- 30 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3099
Inclusion of Speckle Tracking Echocardiography Analysis in the Management of Intrauterine Growth Restrictions—Literature Review and Case Reports
Background/Objectives: The relationship between ultrasound parameters and fetal health in the context of intrauterine growth restriction (IUGR) pregnancies constitutes a significant focus of scholarly research. A comprehensive range of Doppler and echocardiographic evaluations, encompassing the umbilical artery, middle cerebral artery, ductus venosus, uterine arteries, cardiac contractility, ventricular filling, and the thickness of the interventricular septum, has been proposed in pathological pregnancies. Methods: The aim of this paper is to present an examination of these metrics and their implications for fetal health within the framework of IUGR pregnancies and to report a case series in which we analyzed the correlation of these factors. The assessment of these ultrasound indicators can help in better management of the cases in order to obtain better fetal outcomes. Results: Our case study presented dynamics corelated to the after-birth evaluation of the neonate, reflecting the importance of complete ultrasound assessment in high-risk cases. Conclusions: Speckle tracking echocardiography has significantly advanced our understanding of cardiac function in IUGR fetuses. As shown in our cases, it can be used to detect early signs of cardiac dysfunction, differentiating between FGR and SGA.
- 30 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3099
Open AccessInclusion of Speckle Tracking Echocardiography Analysis in the Management of Intrauterine Growth Restrictions—Literature Review and Case Reports
Background/Objectives: The relationship between ultrasound parameters and fetal health in the context of intrauterine growth restriction (IUGR) pregnancies constitutes a significant focus of scholarly research. A comprehensive range of Doppler and echocardiographic evaluations, encompassing the umbilical artery, middle cerebral artery, ductus venosus, uterine arteries, cardiac contractility, ventricular filling, and the thickness of the interventricular septum, has been proposed in pathological pregnancies. Methods: The aim of this paper is to present an examination of these metrics and their implications for fetal health within the framework of IUGR pregnancies and to report a case series in which we analyzed the correlation of these factors. The assessment of these ultrasound indicators can help in better management of the cases in order to obtain better fetal outcomes. Results: Our case study presented dynamics corelated to the after-birth evaluation of the neonate, reflecting the importance of complete ultrasound assessment in high-risk cases. Conclusions: Speckle tracking echocardiography has significantly advanced our understanding of cardiac function in IUGR fetuses. As shown in our cases, it can be used to detect early signs of cardiac dysfunction, differentiating between FGR and SGA.
- 1 January 2025
- Published by MedicHub Media in Ginecologia.ro
- Vol. 47 (1)
The next step in monitoring – the Romanian National Congenital Anomaly Registry (RN-CAR)
Congenital anomalies or congenital malformations involve the presence of malformations with which an individual is born, according to the definition of the World Health Organization. Many of these anomalies have a genetic component, and some can be caused by prenatal exposure to teratogenic factors, while others may have a multifactorial or unknown etiology. Overall, these malformations result in structural changes, functional abnormalities ranging from mild to severe, and can affect the long-term development of the fetus and newborn. Worldwide, any type of congenital malformation has a significant impact on the quality of life of the individuals, as well as on their family. The Romanian Society of Obstetrics and Gynecology had a significant role in elaborating dedicated protocols and in introducing universal prenatal testing over the last 20 years. These actions increased the diagnosis of fetal malformations. Preventing the exposure to known teratogen, improving screening methods and improving environmental and maternal conditions had a significant role in managing the pregnancies. The increased experience among time, the advances in prenatal diagnosis, and the dedicated medical personnel in overspecialized fields led to early diagnosis and different options in the cases with a diagnosis of congenital malformation during pregnancy. The role of a congenital malformations registry is to realize a systematic and comprehensive database that collects, stores and analyzes information about congenital malformations detected at birth or during pregnancy. The importance of such a registry can be seen in other countries that had developed this type of registry for many years. The benefits include essential aspects for public health, medical research and patient care. The registry can enable the identification of trends and patterns in the appearance of congenital malformations. Identifying risk factors and potential causes in some populations can help to implement preventive measures. A well-established registry can contribute to planning necessary medical and social resources for the care of children with congenital malformations. As we consider that the Romanian National Congenital Anomaly Registry (RN-CAR) is the next step in the fetal malformation diagnosis and subsequent management, we present in this paper the benefits of a national database for both patients and doctors.
- 1 January 2025
- Published by MedicHub Media in Ginecologia.ro
- Vol. 47 (1)
The next step in monitoring – the Romanian National Congenital Anomaly Registry (RN-CAR)
Congenital anomalies or congenital malformations involve the presence of malformations with which an individual is born, according to the definition of the World Health Organization. Many of these anomalies have a genetic component, and some can be caused by prenatal exposure to teratogenic factors, while others may have a multifactorial or unknown etiology. Overall, these malformations result in structural changes, functional abnormalities ranging from mild to severe, and can affect the long-term development of the fetus and newborn. Worldwide, any type of congenital malformation has a significant impact on the quality of life of the individuals, as well as on their family. The Romanian Society of Obstetrics and Gynecology had a significant role in elaborating dedicated protocols and in introducing universal prenatal testing over the last 20 years. These actions increased the diagnosis of fetal malformations. Preventing the exposure to known teratogen, improving screening methods and improving environmental and maternal conditions had a significant role in managing the pregnancies. The increased experience among time, the advances in prenatal diagnosis, and the dedicated medical personnel in overspecialized fields led to early diagnosis and different options in the cases with a diagnosis of congenital malformation during pregnancy. The role of a congenital malformations registry is to realize a systematic and comprehensive database that collects, stores and analyzes information about congenital malformations detected at birth or during pregnancy. The importance of such a registry can be seen in other countries that had developed this type of registry for many years. The benefits include essential aspects for public health, medical research and patient care. The registry can enable the identification of trends and patterns in the appearance of congenital malformations. Identifying risk factors and potential causes in some populations can help to implement preventive measures. A well-established registry can contribute to planning necessary medical and social resources for the care of children with congenital malformations. As we consider that the Romanian National Congenital Anomaly Registry (RN-CAR) is the next step in the fetal malformation diagnosis and subsequent management, we present in this paper the benefits of a national database for both patients and doctors.